Salient Pharmaceuticals' Series A Round

Salient Pharmaceuticals raised a round of funding on December 02, 2011.

Salient Pharmaceuticals is a life science company developing a proprietary compound intended for use in treating severe diarrhea associated with chemotherapy, chronic conditions, infectious diseases a…

Articles about Salient Pharmaceuticals' Series A Round: